A previous study reported that baicalin could diminish levels of pro-inflammatory mediators, TNF-α, IL-6 and IL-1β, in acute lung injury, functioning as a potential therapeutic candidate, which was largely consistent with the observations of our study (Meng et al. 2019; Peng et al. 2019). This evidence concerns the gene IL6 and injury.